Author:
Patel Ashmi,Salah Haneen T.,Hamel Remi K.,Hall Elizabeth L.,Crumley Suzanne M.,Woods Karen L.,Goldberg Leonard H.
Reference11 articles.
1. Guidelines of care for the management of basal cell carcinoma;Bichakjian;J Am Acad Dermatol,2018
2. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma;Ally;J Am Acad Dermatol,2014
3. Key clinical adverse events in patients with advanced basal cell carcinoma treated with sonidegib or vismodegib: a post hoc analysis;Gutzmer;Dermatol Ther (Heidelb),2021
4. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib;Chang;J Am Acad Dermatol,2014
5. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial;Tang;Lancet Oncol,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献